how can i qualify for semaglutide Who Prescribe Semaglutide? Prescribers and Online Options Semaglutide for Weight Loss: Eligibility

Weight management has progressed to the point where the development of some powerful tools is feasible

Clinical Trial Results STEP Trials (Semaglutide) The STEP program studied semaglutide 2.4 mg weekly in overweight/obese adults: STEP 1 : 16.9% average weight loss over 68 weeks vs 2.4% placebo STEP 2 (T2D patients): 9.6% weight loss STEP 3 (with behavioral therapy): 16.0% weight loss STEP 5 (2-year data): 15.2% sustained weight loss SURMOUNT Trials (Tirzepatide) The SURMOUNT program studied tirzepatide at 5mg, 10mg, and 15mg weekly: SURMOUNT-1 : 20.9% average weight loss at 15mg over 72 weeks vs 3.1% placebo SURMOUNT-2 (T2D patients): 14.7% at 15mg SURMOUNT-3 (with lifestyle intervention): 26.6% at highest dose SURMOUNT-4 (maintenance): continued weight loss vs weight regain on placebo Head-to-Head No large head-to-head trial has directly compared them at optimal doses for weight loss

Supplementary material The Supplementary Material for this article can be found online at: References 1 Foss-FreitasMCAkinciBLuoYStrattonAOralEA

The Formula: Units to mg (Units 100) Concentration (mg/mL) = Dose in mg Example Tirzepatide patient taking 44 units at 17 mg/mL: (44 100) 17 mg/mL = 7.5 mg So 44 units of Tirzepatide at 17 mg/mL = 7.5 mg of the medication

Common sizes are 2 mg, 5 mg, 10 mg, 15 mg, and 30 mg